share_log

Supernus Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer

SEC ·  Oct 12, 2021 19:55
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.